Latest news with #KhamisAl-Saad
Iraqi News
28-04-2025
- Health
- Iraqi News
Iraq reaches deal with EU firms to build insulin production plant
Baghdad ( – The Iraqi Ministry of Health revealed on Sunday that it signed a Memorandum of Understanding (MoU) with European companies to establish an insulin production plant in the northern Iraqi province of Nineveh. According to a statement cited by the Iraqi News Agency (INA), the MoU was signed with a Polish firm, one of the top four producers of insulin worldwide, and a German corporation. The contractual processes are underway, and the land designated for the construction of the insulin factory has been selected, according to the statement. The idea to produce insulin in Iraq that meets all European requirements was sparked by the Iraqi government's support for pharmaceutical and health industry initiatives. Iraq has a significant demand for insulin, according to Khamis Al-Saad, the undersecretary of the country's Ministry of Health, who told INA that importing the drug from overseas takes an extended period of time. Since this plant would be the first to produce insulin in the region, Al-Saad clarified that the agreement with European firms represents a positive move both nationally and regionally. Patients with diabetes require insulin as a medication, and its timely and consistent supply is crucial, particularly since a shortage can cause patients to have severe health problems. The step is one of the top goals of the Iraqi government's agenda, which Prime Minister Mohammed Shia Al-Sudani highlighted, with a particular emphasis on the health sector.
Iraqi News
27-04-2025
- Health
- Iraqi News
Iraq partners with European firms to build major Insulin plant in Nineveh
Baghdad ( – Iraq's Ministry of Health announced today, Sunday (April 27, 2025), the signing of a Memorandum of Understanding (MoU) with leading European pharmaceutical companies to establish a major insulin production facility in Nineveh governorate. The MoU involves Iraqi company Al-Tharwa Pharmaceutical Industries, an unnamed German firm, and Byton from the Netherlands, noted as one of the world's top four insulin producers. The agreement paves the way for constructing the factory on allocated land in Nineveh, aiming to produce insulin locally to integrated European quality standards. Abdullah Mohammed, MD of Al-Tharwa, confirmed contractual procedures are underway. Officials highlighted the project's significance in meeting Iraq's high demand for insulin and reducing reliance on lengthy import processes. Health Ministry Undersecretary Khamis Al-Saad noted this could be one of the first such plants regionally. The project was spurred by Iraqi government support, particularly the inclusion of sovereign guarantees in the budget, encouraging private sector investment in crucial health projects. This aligns with PM Mohammed Shia Al Sudani's program prioritizing healthcare development and public-private partnerships to improve services for citizens, especially essential treatments like insulin for diabetics.
